Recorded Presentation from the NCCN 2024 Breast Cancer Congress: Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates

Recorded Presentation from the NCCN 2024 Breast Cancer Congress: Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates

This program will provide expert insights on the current recommendations of care for patients with breast cancer and include the latest clinical research updates to assist clinicians in formulating breast cancer management strategies.

  • Provider:National Comprehensive Cancer Network
  • Activity Link: https://education.nccn.org/breast
  • Start Date: 2024-03-15 05:00:00
  • End Date: 2024-03-15 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 1.25 hours
    AMA PRA Category 1 Credit™️: 1.25 hours
    Nursing: 1.25 hours
    Pharmacy: 1.25 hours
    Social Work: 1.25 hours
  • Commercial Support: Source: AstraZeneca (Any division) - Amount: 0.0 - Is Kind Support: False Source: Daiichi Sankyo, Inc. - Amount: 0.0 - Is Kind Support: False Source: Gilead Sciences, Inc. - Amount: 0.0 - Is Kind Support: False Source: Menarini-Stemline - Amount: 0.0 - Is Kind Support: False Source: Merck (Any division) - Amount: 0.0 - Is Kind Support: False Source: Novartis Corporation Pharmaceuticals - Amount: 0.0 - Is Kind Support: False Source: Pfizer (Any division) - Amount: 0.0 - Is Kind Support: False Source: Puma Biotechnology - Amount: 0.0 - Is Kind Support: False Source: Seagen - Amount: 0.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Community/Population Health, Learner Knowledge, Learner/Team Competence, Learner/Team Performance, Patient Health
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.